Crescita Therapeutics Inc (CTX.TO) revealed Loss for third quarter that decreased from last year
The company's bottom line totaled -C$1.036 billion, or -C$0.05 per share. This compares with -C$1.282 billion, or -C$0.06 per share, in last year's third quarter.
The company's revenue for the quarter rose 18.5% to C$3.594 million from C$3.033 million last year.
Crescita Therapeutics Inc earnings at a glance (GAAP) :
-Earnings (Q3): -C$1.036 Bln. vs. -C$1.282 Bln. last year.
-EPS (Q3): -C$0.05 vs. -C$0.06 last year.
-Revenue (Q3): C$3.594 Mln vs. C$3.033 Mln last year.
For comments and feedback: editorial@rttnews.com